Yeast Infection Diagnostics Market

Yeast Infection Diagnostics Market Outlook (2023 to 2033)

The yeast infection diagnostics market size is projected to be worth USD 417.7 Million in 2023. The market is likely to surpass USD 711.4 Million by 2033 at a CAGR of 5.5% during the forecast period. Growing yeast infection incidences is aiding the market growth. When the vagina is infected with Candida, it is referred to as a yeast infection.

Candida is a kind of yeast. Candidiasis is most typically seen as a secondary illness in immunocompromised people. These are frequent dwellers in the mouth cavity, gastrointestinal tract, vagina, penis, and other areas. They only become pathogenic when favorable conditions exist.

It can affect the mouth, vagina, penis, and other areas of the body. Antibiotic use is frequently linked to candidiasis. Cancer cytotoxic treatment can produce Candida albicans fungemia, which develops from fungal translocation across damaged mucosal barriers.

Candidiasis is more common in old age and infants, according to NIH: StatPearls 2023. Yeast infection affects around 37% of newly born newborns in the United States.

Other Drivers Propelling the Demand for Yeast Infection Diagnostics Market include:

• When natural immunity in the body is disrupted, yeast infection occurs. Covid infection has weakened immunity of whole world, making maximum world population susceptible to yeast infection.
• Candida enters the bloodstream through three primary routes: the gastrointestinal tract mucosal barrier, an intravascular catheter, and a localized infection.
• Candida can enter the circulation of both neutropenic and critical care unit patients. Yeast also constitute a typical part of the intestinal microbiota, and any disease that makes an individual immunocompromised might result in systemic candidiasis.
• Yeast growth in catheters that are embedded, especially those with central lines, may occur regardless of the location of implantation or the hub, leading to a subsequent yeast infection.
• Most businesses aspire to develop methods for managing bioinformatics processes using Graphical User Interfaces (GUIs), enabling non-skilled laboratory personnel or researchers to swiftly and efficiently analyze -omics data and deliver clearly interpretable findings.

Challenges for Companies /Manufacturers in the Yeast Infection Diagnostics Market:

• Due to wide range of yeast being able to infect human, the challenge is to determine the causal agent precisely and quickly since this typically directs the right antifungal therapy.
• The use of fungal-omics in detection remains a challenge. -Omics technologies create massive volumes of data, and most centers lack robust computer resources for data processing and storage.
• Molecular approaches to improve yeast infection detection remains confined to a few specialized institutes.
• While the introduction of commercial testing will stimulate wider application, more validation and cost reductions are necessary.

Opportunities in the Yeast Infection Diagnostics Market Industry:

• Next-generation sequencing will offer valuable information on the mycobiome, antifungal resistance mechanisms, as well as broad-range diagnosis straight from the material, which might be crucial for the molecular identification of yeasts beyond Candida species.
• With technology advancements, frontline laboratories want speedy, low-cost, reliable, and simple-to-implement assays to enhance yeast diagnosis. New technologies and diagnostic techniques based on microfluidics, optics, and nanotechnology are currently on their way.

Latest Trends in the Yeast Infection Diagnostics Market:

• The purpose of yeast infection diagnostics is to produce point-of-care testing, which has become a trend in diagnostics, including fungal illnesses. The discipline of fungal infection diagnostics is beginning to capitalize on recent advances in fields like as proteomics and high-throughput generation sequencing.
• Nonetheless, the major businesses and technology developers have seen the clinical sector's enormous potential and are working to build smaller, simpler, and less expensive equipment.
• The introduction of palm-sized sequencing machines onto the market, as well as a growing range of point-of-care testing equipment, presages a technical revolution in diagnostic instruments commercially available to healthcare practitioners.
• The rapid and reliable detection of a little amount of infectious agent remains the primary goal of yeast infection diagnostics. The gadget must also give other pertinent information, such as potential antifungal resistance and illness mode or stage detection.

Attributes	Details
Yeast Infection Diagnostics Market Size (2023)	USD 417.7 Million
Yeast Infection Diagnostics Market Projected Size (2033)	USD 711.4 Million
Value CAGR (2023 to 2033)	5.5%

2012 to 2022 Yeast Infection Diagnostics Market Demand Outlook Compared to 2023 to 2033 Forecast

From 2012 to 2022, the global yeast infection diagnostics market experienced a CAGR of 4.4%, reaching a market size of USD 417.7 Million in 2023.

From 2012 to 2022, the global yeast infection diagnostics market industry witnessed steady growth due to the increased prevalence of yeast infection. According to COVID-19, fungal infections can cause serious disease and death.

COVID-19 with a fungal infection can coexist in some people. COVID-19 therapies, such as steroids and other medicines, can reduce the body's ability to fight fungus.

The creation of diagnostic kits has been facilitated by advances in genomic research and understanding of the genetic underpinnings of yeast specific biomarker.

Future Forecast for Yeast Infection Diagnostics Market Industry:

Looking ahead, the global Yeast Infection Diagnostics Market industry is expected to rise at a CAGR of 5.5% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 711.4 Million by 2033.

The yeast infection diagnostics market industry is expected to continue its growth trajectory from 2023 to 2033. Next generation sequencing has made diagnosis of causal species easy, with intervention of other detection techniques and artificial intelligence. Diagnosis process is prone to become easy, rapid and in small point-of-care testing.

Early identification and diagnosis of yeast infection improves patient health outcomes significantly. Yeast infection diagnostics offer the ability to detect infection and type of causal agent in early-stage of infection, allowing for earlier intervention and better survival rates. The emphasis on early diagnosis is anticipated to drive future demand for yeast infection diagnostic market.

Country-Wise Insights

Yeast Infection Diagnostics Market to Surge in the United States Due to Rising Prevalence of Yeast Infection.

Country	The United States
Market Size (USD Million) by End of Forecast Period (2033)	USD 204.9 Million
CAGR % 2023 to End of Forecast (2033)	4.5%

The Yeast Infection Diagnostics Market industry in the United States is expected to reach a market size of USD 204.9 Million by 2033, expanding at a CAGR of 4.5%. Vaginal candidiasis is the most prevalent among all the yeast infections, according to the Centers for Disease Control and Prevention 2022.

It is considered to be the second most prevalent kind of vaginal infection in the USA, following bacterial vaginal infections. Annually, around 1.4 million outpatient consultations for vaginal candidiasis are made.

Rising Demand for Yeast Infection Diagnostics Market is Due to the Growing Increasing Awareness and Screening Programs.

Country	The United Kingdom
Market Size (USD Million) by End of Forecast Period (2033)	USD 51.6 million
CAGR % 2023 to End of Forecast (2033)	3.7%

The yeast infection diagnostics market industry in the United Kingdom is expected to reach a market value of USD 51.6 Million, expanding at a CAGR of 3.7% during the forecast period. According to the 2013 Health Technology Assessment, Candida albicans represented 61% of all Invasive fungal disease.

According to an article provided by Public Health England 2021, the overall incidence of Candidaemia in England was 3.5 every 100,000 inhabitants in 2020, a modest rise from 2019 (3.1 per 100,000), with older people having the most severe prevalence of Candidaemia.

The rise in frequency between 2019 to 2020 might be attributed to a significant rise in the number of patients referred to intensive care units (ICUs) in the year 2020 as an outcome of the COVID-19 pandemic.

Patients in ICUs are more likely to develop Candidaemia because the environment permits the opportunistic pathogen to grow invasive, and multiple risk factors underlying Candidaemia overlap with features of ICU patients. The present epidemiologic demographics of IFD in UK critical care units is described in the aforementioned paragraph.

Notable Growth Expected in China's Yeast Infection Diagnostics Market as Increasing commercial intervention to manufacture diagnostic kits.

Country	China
Market Size (USD Million) by End of Forecast Period (2033)	USD 64.8 million
CAGR % 2023 to End of Forecast (2033)	6.8%

The yeast infection diagnostics market industry in China is anticipated to reach a market size of USD 64.8 million, moving at a CAGR of 6.8% during the forecast period.

The yeast infection diagnostics market industry in China is expected to grow prominently due to the increasing commercial intervention in production of rapid diagnostic kits and real time PCR kits. As per The Lancet Infectious Diseases today 2018, Chinese, women are the world’s most numerous sufferers of thrush at 29.1 million.

Urn shaped demographics to Drive Market Growth in Japan

Country	Japan
Market Size (USD Million) by End of Forecast Period (2033)	USD 48.2 million
CAGR % 2023 to End of Forecast (2033)	6.4%

The yeast infection diagnostics market industry in Japan is estimated to reach a market size of USD 48.2 million by 2033, thriving at a CAGR of 6.4%. When pre-reproductive and reproductive population are nearly comparable in quantity or proportion, and post-reproductive population have very few, bell-shaped age pyramids arise.

Japanese demography reflects a curve with a bell shape, indicating that Japan has a larger elderly population. According to Geriatrics (Basel) 2020, there is an elevated prevalence of oral Candidiasis diagnosis in reliant Japanese elderly people.

When contrasted with independent older adults, dependent seniors might be more prone to oral Candida albicans infection. As a result, Japan has emerged as a key market for yeast infection diagnostics.

Demand for Yeast Infection Diagnostics Market is Rising Due to Increasing Technological Advancements.

Country	South Korea
Market Size (USD Million) by End of Forecast Period (2033)	USD 5.1 Million
CAGR % 2023 to End of Forecast (2033)	8.2%

The yeast infection diagnostics market industry in South Korea is expected to reach a market size of USD 5.1 million, expanding at a CAGR of 8.2% during the forecast period. South Korea is well-known for its technology breakthroughs and healthcare innovation.

The country's strong emphasis on research and development, along with a favorable regulatory framework, leads to the growth of the yeast infection diagnostics market by allowing the development and commercialization of improved diagnostic technologies.

Category-Wise Insights

Strips to Dominate Therapeutic Area in Yeast Infection Diagnostics Market Industry with 60.2% Market Share in 2022

The test strips are predominant in yeast infection diagnostics market industry with a market share of 60.2% in 2022. Antifungal susceptibility testing (AFST) is currently frequently utilized and recommended in the treatment of patients suffering from persistent fungal infections like candidiasis and aspergillosis.

The average vaginal pH ranges from 3.8 to 5.0. During a vaginal infection, the pH rises to 5.0-5.5 or 6.0-7.5, and vulvovaginal candidiasis is responsible for 20% to 25% of all vaginitis cases. The test strip is used to detect changes in vaginal pH; it is a tiny, paper-like strip that is put into the vagina for a few seconds before being compared to a color chart to ascertain the pH level.

Why Vaginal pH test is more prominent type of diagnostic in Yeast Infection Diagnostic Market

The vaginal pH Test constitutes 61.9% market share globally in 2022. Vaginal pH strip is more prominently used as it is easy to use by the patients. The strip is cost effective with comparison to the other diagnostic kits. It is more convenient and non-invasive method for initial screening of yeast infection.

Which End User Is Widely Adopted In the Market?

The Hospitals are dominating the yeast infection diagnostics market with the market share of 39.2% in 2022. A hospital is able to cut expenses by offering a complete range of services to patients.

Doctors can utilize a variety of diagnostic tests to determine the source of a patient's symptoms. A commitment to provide high-quality care at a reasonable cost. A hospital can assist in identifying potential issues early on, before they become more serious. It enables rapid intervention and therapy, which improves the results for patients.

How Key Players Stay Competitive in the Yeast Infection Diagnostics Market Industry?

The market for yeast infection diagnostics is very competitive, with numerous businesses vying for market supremacy. In order to remain a step ahead of the competition in a scenario like this, major players have to implement smart strategies.

Key Strategies Used by the Participants

Product Innovation

Key players focus on developing and introducing innovative products to address unmet needs in the market. They invest in research and development to improve existing formulations, delivery systems, and enhance the efficacy and safety of the products

Strategic Partnerships and Collaborations

Key players often form strategic partnerships and collaborations with other companies, research institutes, or healthcare organizations, these partnerships allow for knowledge sharing, joint research and development efforts, and access to complementary technologies or expertise.

Expansion into Emerging Markets

Key players strive to expand their presence in different geographic regions to tap into new markets and reach a wider customer base. They may establish subsidiaries, distribution networks. Or strategic alliances in various countries to strengthen their market position.

Mergers and Acquisitions

Companies in the market may engage in mergers or acquisitions to consolidate their product portfolio, acquire new technologies, these strategic moves allow companies to enter new market segments, gain access to novel products or intellectual property, and achieve synergies in terms of research, manufacturing, or distributions.

Key Players in the Yeast Infection Diagnostics Market Industry

• Hologic Inc.
• Becton, Dickinson and Company
• Natureland Health
• Stix's
• PGYARD
• myLAB Box
• Juno Bio
• Seroflora
• PrivaPath Diagnostics
• NutraBlast
• Rite Aid Corporation
• Home Health (UK) Ltd
• Loyalbody
• Savyon Diagnostics
• BIOSYNEX SA
• Quantbiome, Inc.

Key Developments in the Yeast Infection Diagnostics Market:

• In March, 2023, The FDA granted Becton Dickinson 510(k) authorization for their Vaginal Panel test using the COR platform. The organization's high-throughput molecular testing technology for commercial laboratories is called BD COR.
• On July, 2021, Savyon Diagnostics created the SavvyCheck Vaginal Yeast Test, which is part of a large-scale, multi-site clinical investigation being undertaken at military medical centres and headquarters across the United States.

Segmentation Analysis of the Yeast Infection Diagnostics Market

By Product:

• Strips
• Cassettes
• Panel Test

By Test Type:

• Vaginal pH Test
• Nucleic Acid Amplification Testing (NAAT)
• Microbiome Test

By Body Part:

• Vagina
• Penis
• Mouth
• Nail
• Skin folds

By Indication:

• Vulvovaginal Candidiasis
• Trichomoniasis
• Chlamydia
• Gonorrhea
• Bacterial Vaginosis
• Others

By End User:

• Hospitals
• Diagnostics Laboratories
• Specialty Clinics
• Homecare Settings

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East & Africa

Frequently Asked Questions

What is Driving Demand in South Korea?

An increase in technological advancements drives the demand.

What Drives Sales of the Market?

The rapid and reliable detection of a small number of infectious agents drives sales.

What is the Growth Forecast for the Yeast Infection Diagnostics Market in 2023?

The market expands at a CAGR of 5.5% from 2023 to 2033.

How will China Offer Lucrative Growth Opportunities?

The increase in commercial intervention in the production of rapid diagnostic kits raises the demand in China.

What is China’s Market Growth Outlook?

China is likely to expand at a CAGR of 6.8% from 2023 to 2033.